Lecture abstract:

My talk will look at COVID-19 and its nature as a primarily endothelial and vascular disease. I will focus on understanding COVID Associated Coagulopathy (CAC) and specifically the S1 subunit of the spike protein and its ability to form micro clots, resulting in measurable hypoxia in acute COVID and local tissue hypoxia with chronic ischemic reperfusion injury in long COVID.

Jordan Vaughn received his Bachelor’s degree in Chemical Engineering from the University of Alabama, his medical degree from the University of Alabama (UAB) School of Medicine, and completed his residency in Internal Medicine at UAB Hospital.

After finishing training, Dr. Vaughn brought his knowledge of internal medicine to further expand MedHelp Clinics, which was started by his father, Dr. Michael Vaughn, in 1982.

Focused on caring for patients in all aspects of outpatient medicine — acute and chronic, body and spirit — MedHelp Clinics now has six locations, sees over 190,000 patients a year, and employs 18 physicians and over 200 healthcare workers.

As owner and CEO, Dr. Vaughn pushed the organization since the appearance of SARS-CoV2 to be on the leading edge of properly delivering early outpatient treatment for his patients and the Birmingham community. He is now also incorporating this knowledge into the treatment of those with long COVID (post-acute sequelae SARS-CoV-2 infection or PASC), specifically with regard to the spike protein’s ability to cause endothelial damage and clotting of the micro capillaries.